Health
Egyptian Drug Authority Authorizes Biomerica’s Complete Screening Test Portfolio
Authorization Covers Multiple Screening Tests for Cancer and Chronic Disease Risk Detection • Portfolio includes tests for colorectal disease, breast self exam, prostate disease, kidney disease, and H. pylori infection • Designed for early detection of conditions that are related to the most common cancers and chronic diseases • Rapid, easy-to-use, and cost-effective screening for mass and individual use IRVINE, Calif., Dec. 11, 2025 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), a global p
About this update from Biomerica, Inc.
[{"type":"image","alt":"Biomerica, Inc.","displaySize":"","headline":null,"caption":"Biomerica, Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":232,"height":39,"url":"https://media.zenfs.com/en/globenewswire.com/af40ff522792b4c3d1be4034218ddeca"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/m66J9gaNGHXIlBdKngBmxQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTcxO2NmPXdlYnA-/https://media.zenfs.com/en/globenewswire.com/af40ff522792b4c3d1be4034218ddeca","width":232,"height":39}},"lazy":false},{"type":"text","content":"Authorization Covers Multiple Screening Tests for Cancer and Chronic Disease Risk Detection","length":91,"tagName":"p"},{"type":"text","content":"• Portfolio includes tests for colorectal disease, breast self exam, prostate disease, kidney disease, and H. pylori infection","length":126,"tagName":"p"},{"type":"text","content":"• Designed for early detection of conditions that are related to the most common cancers and chronic diseases","length":109,"tagName":"p"},{"type":"text","content":"• Rapid, easy-to-use, and cost-effective screening for mass and individual use","length":78,"tagName":"p"},{"type":"text","content":"IRVINE, Calif., Dec. 11, 2025 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), a global provider of advanced diagnostic solutions, announced today that the Egyptian Drug Authority (EDA) has granted authorization for Biomerica’s complete portfolio of rapid tests, enabling broad access to simple, rapid, and affordable early detection tools for conditions associated with cancers and chronic diseases across Egypt.","length":416,"tagName":"p"},{"type":"text","content":"This authorization allows Biomerica’s screening products to be marketed and distributed throughout Egypt, supporting early identification of conditions associated with colorectal, breast, and prostate cancers, as well as chronic diseases including kidney disease and Helicobacter pylori infection.","length":297,"tagName":"p"},{"type":"text","content":"Comprehensive Screening Portfolio Now Authorized in Egypt","length":57,"tagName":"p"},{"type":"text","content":"The EDA authorization covers the following Biomerica at-home tests:","length":67,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"EZ Detect™ Colon Disease Test – The most convenient fecal occult blood test (FOBT) that detects hidden blood in stool, an early warni...